Atlas Trials

IDH2 Gene Mutation

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch IDH2 Gene Mutation

RecordFirmDate
A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms (NCT04955938)University of Chicago2021-10-29
Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers (NCT04092179)University Health Network, Toronto2020-11-05
IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT (NCT04522895)Heinrich-Heine University, Duesseldorf2020-08-27
Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation (NCT03881735)Roswell Park Cancer Institute2019-12-02
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas (NCT03749187)University of California, San Francisco2019-04-03
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation (NCT03683433)M.D. Anderson Cancer Center2018-09-18
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis (NCT03303950)University of Utah2018-03-30
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome (NCT03383575)M.D. Anderson Cancer Center2018-01-17
Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia (NCT04369287)Istituto Clinico Humanitas2016-01-01

Track IDH2 Gene Mutation automatically

Every clearance here is in the API, with alerts when new ones post.